UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Journal of clinical oncology, 2005-02, Vol.23 (4), p.712-719

2005

Link zum Volltext

Verfügbarkeit prüfen

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7565-7573

2005

Link zum Volltext

Verfügbarkeit prüfen

Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients

Journal of clinical oncology, 2003-03, Vol.21 (5), p.897-906

2003

Link zum Volltext

Verfügbarkeit prüfen

Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5696-5704

2005

Link zum Volltext

Verfügbarkeit prüfen

The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy

Clinical cancer research, 2004-12, Vol.10 (23), p.7792-7798

2004

Link zum Volltext

Verfügbarkeit prüfen

Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7985-7993

2005

Link zum Volltext

Verfügbarkeit prüfen

Ten-year follow-up of helium ion therapy for uveal melanoma

American journal of ophthalmology, 1998, Vol.125 (1), p.81-89

1998

Link zum Volltext

Verfügbarkeit prüfen

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2013-02, Vol.71 (2), p.523-530

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis

Journal of rheumatology, 2005-12, Vol.32 (12), p.2345

2005

Link zum Volltext

Verfügbarkeit prüfen

Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma

International journal of radiation oncology, biology, physics, 1997-12, Vol.39 (5), p.997-1010

1997

Link zum Volltext

Verfügbarkeit prüfen

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

Blood, 2005-06, Vol.105 (12), p.4576-4582

2005

Link zum Volltext

Verfügbarkeit prüfen

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine

European journal of cancer (1990), 2009-06, Vol.45 (9), p.1589-1596

2009

Link zum Volltext

Verfügbarkeit prüfen

131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

The New England journal of medicine, 2005-02, Vol.352 (5), p.441-449

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract B77: Phase I study of TH-302, an investigational hypoxia-targeted drug, in combination with sunitinib

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B77-B77

2013

Link zum Volltext

Verfügbarkeit prüfen

Irradiated Uveal Melanomas: Cytopathologic Correlation With Prognosis

American journal of ophthalmology, 1996-10, Vol.122 (4), p.509-513

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, and Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma

Blood, 2013-11, Vol.122 (21), p.1948-1948

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias

Blood, 2013-11, Vol.122 (21), p.3920-3920

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of TH-302, a hypoxia-activated cytotoxic prodrug, in subjects with advanced leukemias

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6585-6585

2012

Link zum Volltext

Verfügbarkeit prüfen

Orbital metastases: diagnosis and course

British journal of ophthalmology, 1997-05, Vol.81 (5), p.386-390

1997

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific whole-body dosimetry : Principles and a simplified method for clinical implementation

The Journal of nuclear medicine (1978), 1998-08, Vol.39 (8), p.S14-S20

1998

Link zum Volltext

Verfügbarkeit prüfen

Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy

Ophthalmology (Rochester, Minn.), 2002-10, Vol.109 (10), p.1850-1854

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract B185: Bench to bedside experience with TH-302: A tumor-selective hypoxia-activated prodrug as a promising treatment for prostate cancer

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B185-B185

2009

Link zum Volltext

Verfügbarkeit prüfen

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

Journal of clinical oncology, 1995-10, Vol.13 (10), p.2606-2612

1995

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma

American journal of clinical oncology, 2010-04, Vol.33 (2), p.111-116

2010

Link zum Volltext

Verfügbarkeit prüfen

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy

The Journal of nuclear medicine (1978), 2002-03, Vol.43 (3), p.354

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(107)
Bücher
(1)
Reviews
(1)

Sprache

Englisch
(108)
Japanisch
(10)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients

Abbreviated Chemotherapy With Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab for Untreated Follicular Lymphoma

The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy

Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab

Ten-year follow-up of helium ion therapy for uveal melanoma

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis

Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine

131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Abstract B77: Phase I study of TH-302, an investigational hypoxia-targeted drug, in combination with sunitinib

Irradiated Uveal Melanomas: Cytopathologic Correlation With Prognosis

Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, and Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma

A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias

Phase I study of TH-302, a hypoxia-activated cytotoxic prodrug, in subjects with advanced leukemias

Orbital metastases: diagnosis and course

Patient-specific whole-body dosimetry : Principles and a simplified method for clinical implementation

Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy

Abstract B185: Bench to bedside experience with TH-302: A tumor-selective hypoxia-activated prodrug as a promising treatment for prostate cancer

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy

Suchergebnisse filtern